MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Covidien logs first patient in Iliac stent studies | Research Roundup

Covidien logs first patient in Iliac stent studies | Research Roundup

By

Covidien

Covidien Plc. (NYSE:COV) enrolled the first patients into its two Iliac stent trials, Durability and Visibility.

The trials will each enroll 75 patients at up 20 centers in Europe and the U.S. in order to test the safety and effectiveness of Mansfield, Mass.-based Covidien’s Iliac stent systems for patients with peripheral arterial disease.

Both studies have started in Belgium, enrolling patients at AZ St-Blasius in Dendermonde and Imelda Hospital in Bonheiden.

Covidien ranked 9th on the MassDevice Big 100 list of the world’s largest medical device companies.

The Durability trial will test the Protege EverFlex self-expanding stent with delivery technology, and the Visibility study will test the Visi-Pro balloon expandable stent systems.

Visi-Pro and Protege are already available in the U.S. as treatments for malignant neoplasts in the biliary tree, according to the press release, but the studies hope to expand the indications to PAD treatment in the iliac arteries.

Listen to our exclusive podcast of MassDevice publisher Brian Johnson’s intimate interview with Covidien CEO Joe Almeida.

M and A Roundup

Here’s a roundup of recent clinical trial and scientific study news:

  • Artificial lungs inch closer to the real thing by casting aside oxygen tanks
    The next generation of artificial lungs may be able to use air instead of pure oxygen that current man-made lungs require, according to researchers at Case Western Reserve University in Cleveland, Ohio. The device is still years away from human use, but researchers say that by the time it’s ready it’ll only be about the size of a human lung, or around 6 inches by 6 inches by 4 inches.
    Read more

  • Biotronik completes enrollment in 4Ever study, begins enrollment in stent study
    Biotronik AG has been busy with trials in the last month, announcing closed enrollment of its 4Ever study and opening enrollment for its BioFlow II study. The 4Ever study enrolled 120 patients into a physician-initiated trial of the Switzerland-based company’s Astron Pulsar and Pulsar-18 stents in treatment of superficial femoral artery lesions. The stent trial will study about 440 patients to compare Biotronik’s Orsiro drug-eluting stent to Abbott’s (NYSE:ABT) Xience Prime stent.
    Read more

  • Heart pumps are okay for the elderly

    Left ventricular assist devices led to better quality of life in patients over the age of 70, according to a study published in the June issue of the
    Journal of the American College of Cardiology. Patients were implanted with Thoratec Corp.’s (NSDQ:THOR) HeartMate II LVAD, which won FDA clearance in April 2008.
    Read more

    • In case you missed it

    RSS From Medical Design & Outsourcing

    • Forecasting the future of urology with Boston Scientific’s Meghan Scanlon
      Meghan Scanlon, Boston Scientific’s president of urology and pelvic health, discusses the field and the challenges and opportunities ahead. The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field, said Meghan Scanlon, SVP and president of urology and pelvic health at Boston Scientific (NYSE:BSX) That… […]
    • Women researchers receive a fraction of funding from the world’s biggest medtech companies
      The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians. Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments… […]
    • Pentax Medical expands Vizient contract to include pediatric endoscopes
      Pentax Medical today announced it has expanded its contract with Vizient to include pediatric endoscopes. The contract will give Pentax Medical the ability to offer endoscopes to Vizient member hospitals through the Vizient Pediatric Program. The agreement also includes other value-added offerings, education opportunities and best practices. Get the full story on our sister site,… […]
    • Hologic plans to buy Bolder Surgical for $160M
      Hologic Inc. (NSDQ:HOLX) has a $160 million deal to acquire Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing surgical devices. It’s the latest deal by Hologic, which has been spending COVID-19 test revenue generated by its diagnostics business on acquisitions across the company’s business lines, as CFO Karleen Oberton and CEO Steve MacMillan… […]
    • Koya Medical reports positive early results in Dayspring lymphedema trial
      Koya Medical this week announced positive results from a small, ongoing trial comparing its Dayspring compression treatment for lymphedema to a traditional pneumatic compression pump. The Oakland, California-based company secured FDA 510(k) clearance for the device last month, saying it was the first such approval for an active compression treatment enabling movement and mobility with… […]
    • OneProjects raises $17M to advance 4D cardiac imaging
      Irish-German cardiac imaging startup OneProjects today announced $8 million in Series A2 funding and two grants totaling $9 million. The company will use the new funds to complete product development, conduct clinical trials, gain FDA clearance and prepare for U.S. commercialization of the first product developed from its proprietary 4D cardiac imaging platform, Verafeye. The… […]
    • Women in Medtech 2021: Lindsay Fleming, Avient Corp. Commercial Manager, Healthcare — Color & Additives
      Lindsay Fleming is the Healthcare Commercial Manager for the Color & Additives division at Avient Corporation, a premier provider of specialty polymer formulations, color and additive systems, packaging solutions, and polymer distribution. She has been with the company for over 7 years and oversees the commercial growth development of the healthcare segment. She focuses on… […]
    • Women in Medtech 2021: Sarah Ehrlich, Argon Medical Devices Sustaining Mechanical Engineer
      Sarah Ehrlich, sustaining mechanical engineer at Argon Medical Devices, holds a B.S in mechanical engineering from the University of Texas at Tyler. “My parents knew I would become an engineer before I did,” she said. “Growing up, I was the big sister who put back together whatever my younger siblings decided to tear apart. I… […]
    • Four questions with AdvaMed’s Jen Brearey
      Jen Brearey is AdvaMed’s chief financial officer and chief operating officer, as well as executive director for the association’s inclusion diversity programs, which includes the industry initiative AdvaMed Advance and AdvaMed’s Women’s Executive Network. Ahead of our annual Women in Medtech edition of Medical Design & Outsourcing, we asked Brearey to share her expertise on gender… […]
    • Life Spine wins FDA clearance for ProLift micro expandable spacer
      Life Spine announced that it received FDA clearance to market its ProLift micro expandable spacer system for supporting micro-invasive procedures. Huntley, Illinois-based Life Spine designed its ProLift micro to support procedures ranging from endoscopic TLIFs to MIS TLIFs/PLIFs. The platform includes an 8mm width, self-locking expansion at any height (between 8mm and 16mm) to suit… […]
    • Achieve More with Medical Device Training and Certifications
      Any medical professional that deals with complex devices on a regular basis can benefit greatly from a wide range of medical device courses offered by The Center for Professional Innovation and Education (CfPIE). Each course offered is designed to advance your career under the instruction of trained, experienced, and actively practicing professionals in the field.… […]

    Leave a Reply